Your browser doesn't support javascript.
loading
Patient-derived tumor organoids predict responses to irinotecan-based neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
Lv, Tao; Shen, Lijun; Xu, Xiaoya; Yao, Ye; Mu, Peiyuan; Zhang, Hui; Wan, Juefeng; Wang, Yan; Guan, Ruoyu; Li, Xiaomeng; Fu, Guoxiang; Zhang, Long; Wang, Yaqi; Xia, Fan; Hu, Chen; Clevers, Hans; Zhang, Zhen; Hua, Guoqiang.
Afiliação
  • Lv T; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Shen L; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Xu X; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Yao Y; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Mu P; Institute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, China.
  • Zhang H; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Wan J; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Wang Y; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Guan R; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Li X; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Fu G; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Zhang L; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Wang Y; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Xia F; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Hu C; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Clevers H; Institute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, China.
  • Zhang Z; Institute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, China.
  • Hua G; Research and Early Development, D1Med Technology (Shanghai) Inc, Shanghai, China.
Int J Cancer ; 152(3): 524-535, 2023 02 01.
Article em En | MEDLINE | ID: mdl-36161653
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article